about
Development of anticancer agents targeting the Wnt/β-catenin signalingOvarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTENPathway-based classification of cancer subtypes.Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer.Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.Changes in gene expression and cellular architecture in an ovarian cancer progression model.An integrative approach to identifying cancer chemoresistance-associated pathwaysCurcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.β-catenin/Tcf-signaling appears to establish the murine ovarian surface epithelium (OSE) and remains active in selected postnatal OSE cells.Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancersIntegrin regulation of beta-catenin signaling in ovarian carcinoma.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growthInhibition of ovarian cancer proliferation and invasion by pachymic acid.Can we safely target the WNT pathway?Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway.Wnt and hedgehog gene pathway expression in serous ovarian cancerTelomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer riskWNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 proteinExpression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population.Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancerReduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.Safely targeting cancer stem cells via selective catenin coactivator antagonism.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.
P2860
Q26781898-8E6567F3-F2F5-46D7-8A25-A3910396ED25Q26826899-F15BBCD0-EB56-4F91-A43E-A6C5D8F8070CQ27335766-DCF0079C-E258-4A55-86CD-05499718636EQ30527843-53897427-751E-4092-AD5C-E1ECEAD38280Q30983525-6A1C1490-B7A0-4488-B5B0-C6315C03BC94Q33500353-41291341-DA9C-4FD2-9EDF-25765ED9C3C8Q33598945-A837E78B-DB88-4D5D-9244-E01514DC1AF3Q33842047-EBC27896-8CB3-4CE9-9AD1-611DB35AF875Q33853380-6B8936FD-AC81-4EAD-A2BB-4A4B46062D27Q33892483-A8A96971-F46E-40A0-B5C4-8EE77E32443FQ34298272-1B4BF777-E277-4AEA-AFF4-5278E2E8EA90Q34435134-BCF7B09E-2F39-4788-9AA0-2AFBCBE8527FQ35067867-4C6DA07A-471F-4955-8C62-2404401E2222Q35098085-9C54A974-8752-4934-A748-263CB3222DCAQ35133487-44FE91BA-7513-451E-ACFB-CB6DD2D0D4C0Q35281886-A90601F5-F8E4-4355-98A8-E5B0E1074620Q35406457-FE900C9E-BACF-4302-8BB4-462B8602546CQ35591995-58BAC6C5-F3E3-454E-8CFA-4BB6B067F0D3Q35666419-916306E4-BAD8-43D0-BF33-10EAB7CCCF3FQ35774940-A1946F08-B308-4A60-9E59-0209EA55F22FQ35815552-690A4FDB-4C02-4A0E-A306-085CD17C045FQ35840116-7D8F49B1-5424-4B82-909F-03E0E3A33509Q36201267-0D10D638-48F7-440E-ABCD-51F0238B83E6Q36414274-FF306007-0C7D-4016-9C11-2170CCDFA7D2Q36508547-FCF271DC-5B59-40FE-BAFB-1DA410E4C614Q36944293-A3163867-5BF9-4973-B986-CAA3E46A3887Q36959292-317924C0-15BE-4B71-B5FD-7F6706EA22BDQ37286094-D45886F9-FCC3-4072-B4D2-546F16C0663BQ37334480-AF8D7F49-236F-430A-8AC0-3123E495A719Q37506531-90FD557B-D6A6-47DA-A0B2-82094CBB2FB3Q37520401-7C4BDA30-C8A1-4BC7-9572-77A0BFAFD90FQ37589190-40A93A2D-5375-4504-BE3B-AAF5DF9FD84DQ37684607-F35C92CC-B2DF-4D27-A25A-B780C4D469D7Q37697114-D29E5A70-17D7-4A22-A271-142D420EBCCDQ37705457-7EB441E1-73E6-460C-B6A9-DBEA5DC32FE3Q37710265-B878FDF4-BB15-4346-94A8-3341671AE34DQ38034167-D79CDD87-32A7-4703-BE13-150687FCB857Q38224211-4ED81404-D2FF-4306-AAA9-71C1EC0EB9BFQ38432883-32933D4C-B909-4E67-8DB7-8711CA61FAB2Q38596991-80BE946B-06E3-4408-B2B9-0E27EA5FEF2F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Wnt signaling in ovarian tumorigenesis
@en
type
label
Wnt signaling in ovarian tumorigenesis
@en
prefLabel
Wnt signaling in ovarian tumorigenesis
@en
P2093
P2860
P1476
Wnt signaling in ovarian tumorigenesis
@en
P2093
K Planutis
R F Holcombe
T A Gatcliffe
P2860
P304
P356
10.1111/J.1525-1438.2007.01127.X
P577
2007-11-06T00:00:00Z